During the past decade, Centro de Investigación Médica Aguascalientes conducted 12 clinical trials. In the 10-year time frame, 12 clinical trials started and 3 clinical trials were completed, i.e. on average, 25% percent of trials that started reached the finish line to date. In the past 5 years, 7 clinical trials started and 3 clinical trials were completed. i.e. 42.9% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Centro de Investigación Médica Aguascalientes" #1 sponsor was "Eli Lilly and Company" with 5 trials, followed by "Shire" with 3 trials sponsored, "Hoffmann-La Roche" with 1 trials sponsored, "Laboratorios Silanes S.A. de C.V." with 1 trials sponsored and "Laboratorios Sophia S.A de C.V." with 1 trials sponsored. Other sponsors include -4 different institutions and companies that sponsored additional 6 trials in total.

According to Clinical.Site data, the most researched conditions in "Centro de Investigación Médica Aguascalientes" are "Ulcerative Colitis" (3 trials), "Migraine" (2 trials), "ALK+ Advanced NSCLC" (1 trials), "Chronic Migraine" (1 trials) and "Conjunctivitis, Bacterial" (1 trials). Many other conditions were trialed in "Centro de Investigación Médica Aguascalientes" in a lesser frequency.

Most popular intervention types in "Centro de Investigación Médica Aguascalientes" are "Drug" (12 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (5 trials), "Galcanezumab" (2 trials), "Lasmiditan" (2 trials), "Ontamalimab" (2 trials) and "25 mg Ontamalimab" (1 trials). Other intervention names were less common.

The vast majority of trials in "Centro de Investigación Médica Aguascalientes" are 12 trials for "All" genders.

Currently, there are NaN active trials in "Centro de Investigación Médica Aguascalientes". undefined are not yet recruiting, 5 are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Centro de Investigación Médica Aguascalientes, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Centro de Investigación Médica Aguascalientes, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 12 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".

Centro de Investigación Médica Aguascalientes has several departments that took part in Clinical trials: "Oncologico Potosino" - 21 trials